Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP525924.RAh4jSq1fNgTTIsGLVqMX8j4xl8XfkhDXXR19Nesgl9MA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP525924.RAh4jSq1fNgTTIsGLVqMX8j4xl8XfkhDXXR19Nesgl9MA130_assertion type Assertion NP525924.RAh4jSq1fNgTTIsGLVqMX8j4xl8XfkhDXXR19Nesgl9MA130_head.
- NP525924.RAh4jSq1fNgTTIsGLVqMX8j4xl8XfkhDXXR19Nesgl9MA130_assertion description "[The experience of the past 3 years, since the first case of leukemia was reported in a child cured of X-linked severe combined immunodeficiency (X-SCID) by gene therapy, indicates that the potential genotoxicity of retroviral integration in hematopoietic cells will remain a consideration in evaluating the relative risks versus benefits of gene therapy for specific blood disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP525924.RAh4jSq1fNgTTIsGLVqMX8j4xl8XfkhDXXR19Nesgl9MA130_provenance.
- NP525924.RAh4jSq1fNgTTIsGLVqMX8j4xl8XfkhDXXR19Nesgl9MA130_assertion evidence source_evidence_literature NP525924.RAh4jSq1fNgTTIsGLVqMX8j4xl8XfkhDXXR19Nesgl9MA130_provenance.
- NP525924.RAh4jSq1fNgTTIsGLVqMX8j4xl8XfkhDXXR19Nesgl9MA130_assertion SIO_000772 16624621 NP525924.RAh4jSq1fNgTTIsGLVqMX8j4xl8XfkhDXXR19Nesgl9MA130_provenance.
- NP525924.RAh4jSq1fNgTTIsGLVqMX8j4xl8XfkhDXXR19Nesgl9MA130_assertion wasDerivedFrom befree-20140225 NP525924.RAh4jSq1fNgTTIsGLVqMX8j4xl8XfkhDXXR19Nesgl9MA130_provenance.
- NP525924.RAh4jSq1fNgTTIsGLVqMX8j4xl8XfkhDXXR19Nesgl9MA130_assertion wasGeneratedBy ECO_0000203 NP525924.RAh4jSq1fNgTTIsGLVqMX8j4xl8XfkhDXXR19Nesgl9MA130_provenance.